How the skin of patients with psoriasis protects itself from virus infections

October 2, 2013

Scientists at Charité – Universitätsmedizin Berlin have discovered why patients with psoriasis are less susceptible to viral infections than patients suffering from atopic dermatitis (atopic eczema). The reason for this is the larger quantity of special proteins present in psoriatic skin, which inhibit viral replication. The interdisciplinary team under the direction of Dr. Robert Sabat from the Department of Dermatology and the Institute of Medical Immunology, in collaboration with the Institute of Virology and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), has additionally discovered a new function of the immune system. The study is published in the current issue of the journal Science Translational Medicine.

Psoriasis and atopic dermatitis are the two most common chronic diseases of the , from which over 40 million people suffer in the US and in EU alone. They cause persistent visible changes of the skin that severely impact the quality of life of the patients. In addition, the damaged skin barrier enables pathogens, such as viruses, to penetrate the skin and multiply. Surprisingly, only atopic dermatitis patients show a high incidence of cutaneous viral infections, which exacerbate the course of atopic dermatitis and if not treated promptly, might be life-threatening. The authors of the just-published study show that compared to the skin of patients with , the skin of atopic dermatitis patients produces smaller quantities of what are known as antiviral proteins, which inhibit . In the search for the trigger responsible for these differences in protein production in the two skin diseases, the research team came upon the immune messenger interleukin-29.

"Of the thirty messengers produced by the immune that we examined in psoriatic skin, we only found a correlation with the quantities of antiviral proteins for interleukin-29," explains Dr. Kerstin Wolk from the Institute of Medical Immunology at the Charité, one of the study's two first authors. "In fact, interleukin-29 is present in psoriatic skin, but not in affected skin of atopic dermatitis patients." Removing this immune protein from skin samples taken from patients with psoriasis diminishes the quantity of antiviral proteins in these samples. Using experiments with healthy skin, skin models and isolated cells from the upper layer of the skin, the team additionally showed that interleukin-29 is able to stimulate the production of antiviral proteins, and thereby to protect the skin cells from viral infection.

Moreover, the researchers showed that interleukin-29 is produced by a specific population of known as Th17 cells. "These cells promote the production of antiviral proteins and thus, anti-viral defences in the skin cells," explains Dr. Katrin Witte from the Institute of Medical Immunology at the Charité, also a first author of the study. Thus, they simultaneously uncovered a new function of the immune system.

"It is conceivable that the therapeutic administration of interleukin-29 or substances that mimic its effects could increase patients' local defences against viruses. This would be applicable not only for , but also for other chronic inflammatory diseases that take place in epithelia, such as certain lung conditions in which represent a cofactor. This treatment could alleviate the course of such illnesses," states Dr. Robert Sabat, Head of the Psoriasis Research and Treatment Center at the Charité.

Explore further: Itching for new help for eczema: Recently identified immune cells possible therapeutic target

More information: Science Translational Medicine, 25 September 2013, Vol. 5, Issue 204, p. 204ra129, Sci. Transl. Med. DOI: 10.1126/scitranslmed.3006245

Related Stories

Itching for new help for eczema: Recently identified immune cells possible therapeutic target

January 30, 2013
Researchers have identified a previously unknown critical role for a recently identified immune cell population in the progression of atopic dermatitis. The team found an accumulation of innate lymphoid cells in the active ...

Herpes virus exploits immune response to bolster infection

June 6, 2013
Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an ...

Large-scale Japanese genomics project finds eight new loci linked to atopic dermatitis

February 22, 2013
Around one in ten Japanese school children suffer from a debilitating form of eczema known as atopic dermatitis (AD). Despite clear signs that the condition is heritable, the genetic origins of the disease have remained elusive. ...

Skin care tips for psoriasis patients

August 25, 2013
(HealthDay)—Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking and bleeding, an ...

Recommended for you

The skinny on lipid immunology

October 20, 2017
Phospholipids - fat molecules that form the membranes found around cells - make up almost half of the dry weight of cells, but when it comes to autoimmune diseases, their role has largely been overlooked. Recent research ...

Bacterial pathogens outwit host immune defences via stealth mechanisms

October 20, 2017
Despite their relatively small genome in comparison to other bacteria, mycoplasmas can cause persistent and often difficult-to-treat infections in humans and animals. An extensive study by researchers from Vetmeduni Vienna ...

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Researchers release the brakes on the immune system

October 18, 2017
Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism that normally prevent an excessive immune response. Researchers at the ...

How cytoplasmic DNA triggers inflammation in human cells

October 17, 2017
A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.